(Q51161258)

English

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.

scientific article published on 17 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

fatty liver disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

author name string

Salvatore Petta

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Vincent Wai-Sun Wong

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Calogero Cammà

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Jean-Baptiste Hiriart

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Grace Lai-Hung Wong

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Julien Vergniol

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Anthony Wing-Hung Chan

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Vito Di Marco

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Wassil Merrouche

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Henry Lik-Yuen Chan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Marco Barbara

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Brigitte Le-Bail

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Umberto Arena

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Antonio Craxì

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Victor de Ledinghen

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

language of work or name

0 references

publication date

5 November 2016

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

65

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1145-1155

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Hepatocellular cancer: the impact of obesity, type 2 diabetes and a multidisciplinary team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

"Normal" liver stiffness measure (LSM) values are higher in both lean and obese individuals: a population-based study from a developing country.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Learning curve and interobserver reproducibility evaluation of liver stiffness measurement by transient elastography.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

21 January 2018

Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between anthropometric parameters and measurements of liver stiffness by transient elastography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of reliability criteria for liver stiffness evaluation by transient elastography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®

1 reference

https://api.crossref.org/works/10.1002%2FHEP.28843

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.28843

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27639088%20AND%20SRC:MED&resulttype=core&format=json

23 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51161258&oldid=1539206453"